More articles from Therapy Metrics and Intervention Posters

You have access
Quantitative study using 18F-FDG in patients with locally advanced adenocarcinoma of the esophago-gastric junction during induction chemotherapy
C v. Gall, F Lordick, A Afshar-Oromieh, F Giesel, M Weber, L Strauss, A Dimitrakopoulou-Strauss and U Haberkorn

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1626;
You have access
PET/CT imaging of surgical specimens utilizing radiolabeled monoclonal 124I-cG250 antibody: An exploration of imaging histology
Douglas Murrey, Nathan Hall, Eamonn Bahnson, Robert Bahnson, Edward Martin and Michael Knopp

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1653;
You have access
The significance of Tc-99m-MAA SPECT-CT liver perfusion imaging in treatment planning for yttrium 90 microsphere selective internal radiation treatment
Hojjat Ahmadzadehfar, Amir Sabet, Kim Biermann, Holger Brockmann, Christiane Kuhl, Kai Wilhelm, Marianne Muckle, Hans-Juergen Biersack and Samer Ezziddin

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1662;
You have access
Physiologically based pharmacokinetic modeling: Investigating bivalent antibody-antigen interaction
Peter Kletting, Sven Reske and Gerhard Glatting

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1631;
You have access
Characterization and validation by [18F]-FDG micro-PET and micro-MRI studies of two endometrial carcinoma models
Celine Lefebvre Lacoeuille, Franck Lacoeuille, Francis Bouchet, Marion Fusellier, Francois Hindre, Laurent Lemaire, Jean Jacques Le Jeune, Philippe Descamps and O Couturier

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1634;
You have access
Monoclonal antibody 14C5: Potential use in radioimmunotherapy of pancreatic cancer
Liesbet Vervoort, Ingrid Burvenich, Magali Van Steenkiste, Sofie Metsu and Filip De Vos

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1643;
You have access
Impact of Tc-99m macro aggregated albumin (MAA) SPECT/CT imaging in planning Yttrium-90 radiomicrosphere therapy.
Shyam Srinivas, Naveen Venigalla, Sankaran Shrikanthan, Richard Brunken, James Spain and Abraham Levitin

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1664;
You have access
Optimizing radioimmunotherapy with anti-CD66 antibody using physiologically based pharmacokinetic (PBPK) modeling
Peter Kletting, Thomas Kull, Donald Bunjes, Sven Reske and Gerhard Glatting

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1630;
You have access
Dynamic MET PET analysis has an additional value for differentiating tumors from granulomas: An experimental study using small animal PET
Songji Zhao, Yuji Kuge, Min Yi, Yan Zhao, Satoshi Takeuchi, Toshiyuki Hatano, Koutarou Suzuki, Keiichi Magota, Masashi Kohanawa and Nagara Tamaki

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1650;
You have access
Empiric dose method as secondary calculation for determining activity for resin microsphere treatments
Laura Doyle, Njogu Njuguna, Daniel Brown, P. Rani Anne', Carin Gonsalves, David Eschelman, Ying Xiao and Yan Yu

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1633;

Main menu

User menu

Search

More articles from Therapy Metrics and Intervention Posters

Pages